[
    [
        {
            "time": "2023-10-01",
            "original_text": "Market check: Stocks open lower, yield curve steepens, oil under pressure",
            "features": {
                "keywords": [
                    "Stocks",
                    "open lower",
                    "yield curve steepens",
                    "oil under pressure"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "energy",
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Market check: Stocks open lower, yield curve steepens, oil under pressure",
                "Correlation": 6,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 10,
                "Headline_Structure": 5,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "LVIP ClearBridge Franklin Select Large Cap Managed Volatility Fund Buys HubSpot Inc, Cisco ...",
            "features": {
                "keywords": [
                    "LVIP",
                    "ClearBridge",
                    "Franklin",
                    "Select",
                    "Large Cap",
                    "Managed Volatility Fund",
                    "Buys",
                    "HubSpot",
                    "Cisco"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "technology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "LVIP ClearBridge Franklin Select Large Cap Managed Volatility Fund Buys HubSpot Inc, Cisco ...",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "FDA Approves Coherus' Version of Abbvie's Humira, Best-Selling Drug in the U.S.",
            "features": {
                "keywords": [
                    "FDA",
                    "Approves",
                    "Coherus",
                    "Version",
                    "AbbVie",
                    "Humira",
                    "Best-Selling Drug",
                    "U.S."
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "FDA Approves Coherus' Version of Abbvie's Humira, Best-Selling Drug in the U.S.",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Coherus Gets FDA Approval for Biosimilar to AbbVie's Humira",
            "features": {
                "keywords": [
                    "Coherus",
                    "Gets",
                    "FDA",
                    "Approval",
                    "Biosimilar",
                    "AbbVie",
                    "Humira"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Coherus Gets FDA Approval for Biosimilar to AbbVie's Humira",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]